Latest Breaking News On - Contract development manufacturing organization - Page 8 : comparemela.com

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs

PolyPeptide Group / Key word: Partnership PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs. | May 9, 2023

Christian schwarzNumaferm gmbOlivier ludemann hombourgerChristopher kleinHead of investor relations corporate communicationsSwiss exchangePolypeptide groupContract development manufacturing organizationPreferred partner collaboration agreementDirector global innovationGreen chemistryContract developmentManufacturing organizationInvestor relationsManaging directorPolypeptide group ag stock exchange

Liminal BioSciences Inc : Liminal BioSciences Reports First Quarter Financial Results 2023

GPR84 antagonist program and OXER1 antagonist program on track to meet previously stated milestones in 2023Closed March 31, 2023 with just over CAD26.9 million cash on hand, expecting to provide

United kingdomKaitlin gallagherShrinal inamdarBruce pritchardPrnewswire liminal biosciences incContract development manufacturing organizationExchange commissionLiminal biosciences incSecurities exchangeChief executive officerQuarter ended marchContract development manufacturingSecurities actSecurities exchange actLiminal bioscienceNasdaq listing rule

Liminal BioSciences Reports First Quarter Financial Results 2023

/PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a development-stage biopharmaceutical company focused on.

United kingdomBruce pritchardContract development manufacturing organizationLiminal biosciences incChief executive officerQuarter ended marchContract development manufacturingLiminal biosciences inc

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable p

PolyPeptide Group / Key word(s): PartnershipPolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs 09.05.2023 / 20:40 CET/CESTMedia release          PolyPeptide and Numaferm announce partner.

Christopher kleinOlivier ludemann hombourgerChristian schwarzNumaferm gmbPolypeptide groupPolypeptide group keyHead of investor relations corporate communicationsContract development manufacturing organizationSwiss exchangePreferred partner collaboration agreementDirector global innovationGreen chemistryContract developmentManufacturing organizationInvestor relationsManaging director

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Christopher kleinOlivier ludemann hombourgerChristian schwarzNumaferm gmbPolypeptide groupSwiss exchangeContract development manufacturing organizationHead of investor relations corporate communicationsPreferred partner collaboration agreementDirector global innovationGreen chemistryContract developmentManufacturing organizationInvestor relationsManaging director